Cardiovascular and Functional Effects of Testosterone Therapy for Hypogonadal Patients With Heart Failure
Withdrawn prior to enrolment
Phase of Trial: Phase II
Latest Information Update: 21 Jul 2017
At a glance
- Drugs Testosterone (Primary)
- Indications Heart failure; Hypogonadism
- Focus Adverse reactions; Biomarker; Therapeutic Use
- 14 Jul 2017 Status changed from not yet recruiting to withdrawn prior to enrolment.
- 07 Jul 2011 Planned initiation date changed from 1 Jun 2011 to 1 Jul 2011 as reported by ClinicalTrials.gov.
- 24 Jun 2011 New trial record